Zhang MH, Blair MP, Ham SA, et al. - In this retrospective cohort study, researchers reported ocular and neurodevelopmental outcomes among infants treated for retinopathy of prematurity (ROP) in a nationwide health insurance claims database. The sample consisted of 298 infants treated with laser or anti-vascular endothelial growth factor (VEGF) injection identified in the MarketScan database (2011–2017) with 2-year follow-up. The incidence of retinal detachment after 2 years was comparable compared anti-VEGF to the laser. There were no variations in language, motor, or cognitive delays despite the higher rates of underlying neurologic comorbidity in the injection group.